The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker Implantation.
Amar Krishnaswamy, Yasser Sammour, Antonio Mangieri...
https://pubmed.ncbi.nlm.nih.gov/32305392/Actively Recruiting
Led by National and Kapodistrian University of Athens · Updated on 2024-12-12
400
Participants Needed
2
Research Sites
35 weeks
Total Duration
Researchers are studying patients undergoing Transcatheter Aortic Valve Implantation TAVI to address the challenge of needing permanent pacemaker implantation PPI after TAVI. This trial investigates the use of rapid atrial pacing RAP, a simple test using a temporary pacemaker lead, as a way to predict which patients might require PPI. The study aims to clarify the value of RAP in improving decision-making post-TAVI given the current variability in PPI rates and the impact of PPI on long-term health outcomes. The study involves placing a temporary pacemaker lead in the right atrium before and after the TAVI procedure in patients who are stable and not dependent on a pacemaker. RAP is performed by increasing the pacing rate until a certain type of atrioventricular block is observed or a maximum rate of 150 beats per minute is reached. The test is done twice, before and after the valve implantation, to record the hearts response to pacing. Participants will be closely monitored during the procedure and follow-up visits. Data collected include electrocardiograms and RAP test results, with ongoing recording of any adverse events. The main outcome measured is the rate of permanent pacemaker implantation within 30 days after TAVI, along with mortality and PPI rates tracked at 6 and 12 months. Investigators will maintain detailed records throughout the trial to ensure safety and accurate data reporting.
CONDITIONS
Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation
L
Leonidas Koliastasis, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National and Kapodistrian University of Athens
Lead Sponsor
Centre Hospitalier Universitaire Saint Pierre
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Procedure day
Participants undergo Transcatheter Aortic Valve Implantation (TAVI) with temporary pacemaker electrode placement. Rapid atrial pacing (RAP) tests are performed before and after the TAVI procedure to assess atrioventricular conduction.
1 visit (in-person) on the day of TAVI
Duration - 12 months
Participants are monitored for permanent pacemaker implantation and mortality outcomes for up to 12 months following the TAVI procedure.
Follow-up visits as per local practice up to 12 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Amar Krishnaswamy, Yasser Sammour, Antonio Mangieri...
https://pubmed.ncbi.nlm.nih.gov/32305392/Bryan E-Xin Tan, Anas Hashem, Leela K T Boppana...
https://pubmed.ncbi.nlm.nih.gov/37698294/Sven Knecht, Beat Schaer, Tobias Reichlin...
https://pubmed.ncbi.nlm.nih.gov/32089049/Leonidas Koliastasis, Ioannis Doundoulakis, Dimitrios Tsiachris...
https://pubmed.ncbi.nlm.nih.gov/40927105/National and Kapodistrian University of Athens
Lead Sponsor
Centre Hospitalier Universitaire Saint Pierre
Collaborating Sponsor